TCHBF (Tecan Group AG) Debt-to-EBITDA : 2.47 (As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Tecan Group AG Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Tecan Group AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $13 Mil. Tecan Group AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $340 Mil. Tecan Group AG's annualized EBITDA for the quarter that ended in Jun. 2024 was $143 Mil. Tecan Group AG's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2024 was 2.47.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Tecan Group AG's Debt-to-EBITDA or its related term are showing as below:

TCHBF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.02 Med: 0.19 Max: 1.82
Current: 1.82

During the past 13 years, the highest Debt-to-EBITDA Ratio of Tecan Group AG was 1.82. The lowest was 0.02. And the median was 0.19.

TCHBF's Debt-to-EBITDA is ranked worse than
56.41% of 429 companies
in the Medical Devices & Instruments industry
Industry Median: 1.54 vs TCHBF: 1.82

Tecan Group AG Debt-to-EBITDA Historical Data

The historical data trend for Tecan Group AG's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tecan Group AG Debt-to-EBITDA Chart

Tecan Group AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

Get a 7-Day Free Trial

0.41

0.25

1.56

1.46

1.54

Tecan Group AG Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-EBITDA	Get a 7-Day Free Trial															1.36	1.58	1.56	1.44	2.47

Competitive Comparison of Tecan Group AG's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Tecan Group AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tecan Group AG's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tecan Group AG's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Tecan Group AG's Debt-to-EBITDA falls into.

Tecan Group AG Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Tecan Group AG's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(14.154	+	351.358)	/	238.127
	=	1.53

Tecan Group AG's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(12.872	+	340.169)	/	143
	=	2.47

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Jun. 2024) EBITDA data.

Tecan Group AG (OTCPK:TCHBF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Tecan Group AG Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Tecan Group AG's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Tecan Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tecan Group AG (OTCPK:TCHBF) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

TECNz:UK 0QLN:UK TECN:Switzerland

Address

Seestrasse 103, Mannedorf, CHE, 8708

Website

https://www.tecan.com

Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, and Partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their own names. A majority proportion of Tecan's revenue is generated in the Americas and Europe.